Related Experiment Videos
[Application hemostatic drug in capillary-parenchymatous bleeding].
Khirurgiia
|October 13, 2004
Summary
A new hemostatic drug, thrombocol, demonstrated superior efficacy in controlling capillary-parenchymatous hemorrhage in rabbits. Its excellent hygroscopicity, adhesion, and plasticity offer a better hemostatic effect than other collagen-based agents.
Area of Science:
- Biomedical research
- Pharmacology
- Hemostasis
Context:
- Capillary-parenchymatous hemorrhage presents a significant clinical challenge.
- Development of effective hemostatic agents is crucial for surgical and trauma care.
- Existing collagen-based hemostats have varying degrees of efficacy.
Purpose:
- To evaluate the specific activity and hemostatic potential of a novel drug, thrombocol.
- To compare the efficacy of thrombocol against other commercially available hemostatic agents.
- To assess key properties of thrombocol, including hygroscopicity, adhesion, and plasticity.
Summary:
- Thrombocol was investigated for its hemostatic properties in experimental capillary-parenchymatous hemorrhage models using laboratory rabbits.
- Its performance was benchmarked against carbocol, combutek-2, super-4, collastipt, and collagen sponge.
- Results indicate thrombocol possesses high hygroscopicity, excellent wound adhesion, and superior plasticity, leading to a better hemostatic effect.
Impact:
- Thrombocol shows promise as a highly effective hemostatic agent.
- The drug's properties suggest potential for improved management of bleeding in clinical settings.
- Findings contribute to the field of hemostatic drug development and application.